FDA Inspection 1280551 — Jiangxi Fushine Pharmaceutical Co., Ltd.
The FDA completed an inspection of Jiangxi Fushine Pharmaceutical Co., Ltd. on Aug 14, 2025 in Jing Dezhen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jing Dezhen (China)